NCT02669225View on ClinicalTrials.gov

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 2, 2016

Primary Completion Date

January 24, 2017

Study Completion Date

July 11, 2018

Conditions
Normal Physiology
Interventions
OTHER

[18F]florbetaben

PET radiotracer to image Amyloid beta (AB) load in human brain.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

NCT02669225 - Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People | Biotech Hunter | Biotech Hunter